What is ForSight Robotics?
ForSight Robotics is at the forefront of revolutionizing ophthalmic surgery with its proprietary ORYOM platform. This next-generation robotic system is designed to enhance precision and improve patient outcomes in eye care procedures. The company's commitment to robust technological innovation, coupled with clear clinical traction, positions it to significantly transform the landscape of vision correction and treatment worldwide.
How much funding has ForSight Robotics raised?
ForSight Robotics has raised a total of $190M across 3 funding rounds:
Angel/Seed
$10M
Series A
$55M
Series B
$125M
Angel/Seed (2021): $10M with participation from Eclipse Ventures Incorporated and MITHRIL CAPITAL PLC
Series A (2022): $55M led by Eclipse Ventures, Adani, and MITHRIL CAPITAL
Series B (2025): $125M supported by Adani and Eclipse Automation
Key Investors in ForSight Robotics
Adani
Established in 1988, Adani provides a multitude of services within various industries. Some of the industrial services they provide include aerospace and defense manufacturing, energy transmission and distribution, mining, real estate, transportation logistics, and more. This company is headquartered in Ahmedabad, India.
Eclipse Ventures
Eclipse Ventures is a venture capital firm that typically invests in early-stage technology companies. Their focus often includes disruptive innovations and companies with strong potential for growth in sectors like advanced manufacturing and software.
Eclipse Automation
Eclipse Automation Inc is a custom industrial automation company. The company provides services such as redesign, spare parts, retrofits, equipment audits, and upgrades. The company was founded in 2001 and is based in Cambridge, Canada.
What's next for ForSight Robotics?
The substantial enterprise-level funding, culminating in a Series B round, indicates ForSight Robotics is poised for significant scaling and market expansion. This capital injection will likely fuel further research and development, accelerate commercialization efforts, and bolster the company's global market penetration. The strategic backing from prominent investors suggests confidence in ForSight Robotics' ability to lead the next era of robotic ophthalmic surgery and achieve widespread adoption.
See full ForSight Robotics company page
